iOnctura Employee Directory
Biotechnology ResearchGeneva, Switzerland11-50 Employees
iOnctura is a clinical-stage biotechnology company based in Geneva, Switzerland, focused on developing precision, orally delivered therapies for neglected and hard-to-treat cancers. Its lead programs, roginolisib and cambritaxestat, sit in mid-stage clinical development; roginolisib is an allosteric PI3Kδ modulator and cambritaxestat an autotaxin inhibitor. The company aims to extend survival and healthspan by targeting cancers through novel biological mechanisms, with an emphasis on oral administration. iOnctura expanded its clinical program into the United States in 2025, enabling collaboration with leading cancer centers such as Dana-Farber Cancer Institute. The company operates in the biotechnology research sector and has undertaken leadership changes in 2025 as it advances deeper into Phase II testing for its lead candidate.
1-888-653-2347 
support@leadiq.com 
